Calcium and Colecalciferol



Similar documents
(NON-PRESCRIPTION) LEAFLET: USER INFORMATION. CALTRATE VITAMIN D3 600mg/400 IU, film-coated tablet Calcium and Cholecalciferol

Package leaflet: Information for the patient. Cholecalciferol mibe 500 IE, tabletten Cholecalciferol. For use in infants, children and adults

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.

MRP-No. DE/H/0279/001/P/002 Dr. Scheffler Vitamin C, 1000mg, effervescent tablets

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate

There is a risk of renal impairment in dehydrated children and adolescents.

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

Irish Medicines Board

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol

Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. /.../ 2.5 mg orodispersible tablets. Desloratadine

Share the important information in this Medication Guide with members of your household.

Package leaflet: Information for the user. Ondemet 4mg and 8mg Tablets (Ondansetron)

Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET. Forceval Junior Capsules

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

Prochlorperazine 3 mg Buccal Tablets (PROCHLORPERAZINE MALEATE)

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin 500 mg film-coated tablets Metformin 850 mg film-coated tablets. Metformin hydrochloride

Tradol SR 100mg Prolonged Release Tablets Tramadol hydrochloride

2 What you need to know before you have Ampiclox

PATIENT INFORMATION LEAFLET. Forceval Capsules

DULCOLAX Tablets and Suppositories Bisacodyl

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

Patient Medication Guide Brochure

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

Read all of this leaflet carefully before you start taking this medicine

MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

Package Leaflet: Information for the user. <Levetiracetam 750 mg, film-coated tablets> <Levetiracetam 1000 mg, film-coated tablets> Levetiracetam

PACKAGE LEAFLET

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

[For POM]: Read all of this leaflet carefully before you start using this medicine.

PACKAGE LEAFLET: INFORMATION FOR THE USER. METFORMINE MYLAN 850 mg dispersible tablets metformin hydrochloride

MEDGUIDE SECTION. What is the most important information I should know about SEROQUEL? SEROQUEL may cause serious side effects, including:

PATIENT INFORMATION LEAFLET: CENTRUM. Read the contents of this leaflet carefully before you start using CENTRUM, because it

IMPORTANT: PLEASE READ

Amlodipine 5 and 10 mg tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

Restandol Testocaps, 40mg CAPSULES, SOFT Testosterone undecanoate

PACKAGE LEAFLET Page 1 of 7

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

Package leaflet: Information for the user. Maxtrex 2.5mg Tablets methotrexate

Dalacin C 150 mg Hard Capsules Clindamycin (as clindamycin hydrochloride)

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets

CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. sacubitril/valsartan film-coated tablets

Patient Information Once Weekly FOSAMAX (FOSS-ah-max) (alendronate sodium) Tablets and Oral Solution

PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 2.5 mg Tablets

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

Rubifen SR 20 mg slow release tablets

Motilium 1mg/ml Oral Suspension Domperidone

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

Take special care with Septrin Taking other medicines Taking Septrin with food and drink

N HUMAN Novo Nordisk Patient Information for Novolin N

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

Prednisolone 2.5mg tablets (enteric-coated)

Vibramycin Capsules Doxycycline hyclate capsules USP. Vibra-Tabs Film Coated Tablets Doxycycline hyclate tablets USP

Public Assessment Report. UK National Procedure. (colecalciferol) PL 16508/0047 PL 16508/0048. ProStrakan Ltd.

Package leaflet: Information for the user

For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only OR for Specialist Use only

NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam

1 What Anapen is and what it is used for?

What Codeine Phosphate Tablets are used for

Package leaflet: Information for the patient

IMPORTANT: PLEASE READ

2. What you need to know before you take Restandol Testocaps

Package leaflet: Information for the user Naltrexone Hydrochloride 50 mg film-coated tablets Naltrexone Hydrochloride

SYNACTHEN i.m./i.v. tetracosactide hexaacetate

Zomig Nasal Spray. Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION

Galvumet Vildagliptin/Metformin hydrochloride Consumer Medicine Information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Early Access to Medicines Scheme Treatment protocol Information for patients

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

1. What Xylocaine with adrenaline is and what it is used for

1. What Olanzapine Tablets is and what it is used for

Medication Guide. Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood.

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

This leaflet answers some common questions about ARROW - MELOXICAM.

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

What is in this leaflet. 3. How to take Zimovane 4. Possible side effects 5. How to store Zimovane 6. Contents of the pack and other information

PHARMACIST DETACH HERE AND GIVE TO PATIENT

Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide

(NL/H/ / ) FLECAINIDE ACETATE 100 MG; 50 MG TABLET Package leaflet: Information for the user

STRATTERA (Stra-TAIR-a)

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg Film-coated Tablets 500 mg/125 mg film-coated tablets

Gabin 100mg, 300mg & 400mg Capsules GABAPENTIN

Package leaflet: Information for the patient. Desloratadine Actavis 5 mg orodispersible tablets desloratadine

Salazopyrin Tablets. 500 mg. Sulfasalazine POM. 112 Tablets. Each tablet contains sulfasalazine 500 mg. Use as directed by a doctor. Oral use.

PRODUCT MONOGRAPH. Pr PROLOPA. levodopa and benserazide combination. Capsules , , Pharmaceutical standard: professed

Package leaflet: Information for the user

SYNACTHEN DEPOT i.m. (tetracosactide hexaacetate) 1 mg/ml Suspension for injection

Trileptal (Oxcarbazepine)

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride

Transcription:

30042015 PACKAGE LEAFLET: INFORMATION FOR THE USER <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> Calcium and Colecalciferol Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> carefully to get the best results from it. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must contact a doctor if your symptoms worsen or do not improve. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> is and what it is used for 2. Before you take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> 3. How to take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> 4. Possible side effects 5. How to store <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> 6. Further information 1. WHAT <CALCIUM 1000 MG / VITAMIN D 3 880 IU, CHEWABLE TABLETS> IS AND WHAT IT IS USED FOR <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> is a calcium-vitamin D 3-supplement. It is used - to prevent and treat a lack of calcium and vitamin D in the elderly. - for vitamin D- and calcium supplementation as supportive treatment of osteoporosis (brittle bones). 2. BEFORE YOU TAKE <CALCIUM 1000 MG / VITAMIN D 3 880 IU, CHEWABLE TABLETS> Do not take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> - if you are allergic (hypersensitive) to calcium, vitamin D 3 or any of the other ingredients of <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> - if you have high levels of calcium in your blood (hypercalcaemia) - if you have increased excretion of calcium with your urine (hypercalciuria) - if you suffer from overactive parathyroid glands (hyperparathyroidism) - if you suffer from bone marrow cancer (myeloma) - if you suffer from cancer that has affected your bones (bone metastases). - if you have a restraint of the limbs (prolonged immobilisation) accompanied with hypercalcaemia and / or hypercalciuria - if you have kidney stones (nephrolithiasis) - if you have calcium deposits in your kidneys (nephrocalcinosis) 1

- if you suffer from an excessive supply of vitamin D (hypervitaminosis D) - if you have severe kidney problems Take special care with <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> - during long-term treatment the levels of calcium in your blood and urine and your kidney function have to be monitored regularly. This is especially important if you have a tendency to develop kidney stones. Depending on your blood levels your doctor might reduce the dosage or discontinue the treatment. - if you are simultaneously being treated with cardiac glycosides or thiazide diuretics (water tablets) for heart problems the levels of calcium in your blood and urine and your kidney function have to be monitored regularly. Depending on your blood levels your doctor might reduce the dosage or discontinue the treatment. - if you suffer from kidney problems you have to take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> with special care. Your calcium levels of the blood and urine have to be checked. If you suffer from severe kidney problems, use other forms of vitamin D than cholecalciferol. - Take additional supplementation of calcium and vitamin D only under medical supervision and your doctor will require frequent monitoring of the calcium levels in the blood and urine. - Take special care when taking <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> if you suffer from sarcoidosis (an immune system disorder which may affect your liver, lung, skin or lymph nodes). There is a risk that the effect of this medicinal product gets too strong which can result in an overdose of calcium in the body. The levels of calcium in the blood and urine have to be monitored. - if you are immobile and are suffering from osteoporosis this medicinal product has to be used with special care, as the level of calcium in your blood might increase. <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> are not intended for use in children and adolescents. Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. - In the case of simultaneous treatment with digitalis glycosides (cardiac glycosides derived from foxglove), cardiac arrhythmias can occur. Rigorous medical monitoring including an ECG and measurement of the blood calcium level is therefore necessary. - In the case of simultaneous administration of diuretics of the thiazide drug class (also called water tablets), the blood calcium level should be regularly monitored since thiazides decrease the excretion of calcium in the urine. - The absorption and thus also the effectiveness of certain antibiotics (called tetracyclines) are decreased by the simultaneous administration of <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>. These drugs should be taken at least 2 hours before or 4-6 hours after <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>. - Furthermore, other medicines such as sodium fluoride (used to strengthen the tooth enamel or to treat osteoporosis) and bisphosphonate (used to treat osteoporosis) drugs are affected by interactions. These products should therefore be taken at least 3 hours before <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>. - As long an interval as possible should be left between the administration of cholestyramine (a product to lower raised cholesterol levels) or laxatives such as liquid paraffin and <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> since otherwise vitamin D is not absorbed properly. - The simultaneous administration of <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> and phenytoin (a product for the treatment of epilepsy) or barbiturates (hypnotics) can result in a reduction in the effect of vitamin D. - The simultaneous administration of <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> and glucocorticoids (e. g. cortisone) can result in a reduction in the effect of vitamin D and to a decreased calcium level in the blood. - The additional supplementation of calcium and vitamin D should be given only under medical supervision and will require frequent monitoring of the calcium levels in the blood and urine. 2

- Calcium can reduce the effect of levothyroxine (used to treat thyroid deficiency). For this reason, levothyroxine should be taken at least four hours before or four hours after <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>. - The effect of quinolone antibiotics may be reduced if taken at the same time as calcium. Take quinolone antibiotics two hours before or six hours after taking <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>. - Calcium salts may decrease the absorption of iron, zinc and strontium ranelate. Consequently iron, zinc or strontium ranelate preparations should be taken at least two hours before or after <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>. Taking <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> with food and drink You can take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> at any time, with or without food. Please notice that oxalic acid (contained in spinach and rhubarb) and phytic acid (contained in wholegrain cereals) can reduce the amount of calcium you absorb in your bowel. In the 2 hours before or after eating food containing high amounts of oxalic or phytic acid patients should not take medicinal products that contain calcium. Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. If you are pregnant you may use <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> in case of a calcium and vitamin D deficiency. The daily dose of half a tablet must not be exceeded. During pregnancy the total daily amount of calcium should not be higher than 1,500 mg and the total daily amount of vitamin D 3 should not be higher than 600 IU (International Units). Long-term overdose of calcium and vitamin D during pregnancy must be avoided since this may lead to high levels of calcium in the blood and may have a negative effect on the unborn child. <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> can be used during breast-feeding. As calcium and vitamin D pass into breast-milk check with your doctor first if your child receives any other products containing vitamin D. Driving and using machines <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> has no influence on your ability to drive and use machines. Important information about some of the ingredients of <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> This medicine contains aspartame (E951), a source of phenylalanine which may be harmful for people with phenylketonuria. This medicine also contains sorbitol (E420), isomalt (E953) and sucrose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. 3. HOW TO TAKE <CALCIUM 1000 MG / VITAMIN D 3 880 IU, CHEWABLE TABLETS> Always take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> exactly as your doctor or pharmacist has told you. You should check with your doctor or pharmacist if you are not sure. Always take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> exactly as described in this leaflet. You should check with your doctor or pharmacist if you are not sure. Dosage If not told otherwise by your doctor the usual dose is: 3

Adults and elderly take 1 chewable tablet daily (corresponding to 1,000 mg of calcium and 880 IU (International Units) of vitamin D 3). Pregnant women take only half a chewable tablet daily (corresponding to 500 mg of calcium and 440 IU (International Units) of vitamin D 3). The daily dose of half a tablet must not be exceeded. Method of administration The tablet has to be chewed before it is swallowed. It should be taken at any time, with or without food. Duration of treatment <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> should be taken as long-term treatment. Talk to your doctor how long you should take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> (see also section 2, Take special care with <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>). If you take more <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> than you should Overdose of <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> may lead to symptoms such as feeling sick (nausea), vomiting, excessive thirst, increased urine output, depletion of body fluids or constipation, abdominal pain, muscle weakness, tiredness, mental disturbances, lack of appetite, bone pain, kidney problems and, in severe cases, irregular heartbeat. Very rarely in addition: irritability, continuing headache, lightheadedness, muscle spasms, twitches and tingling sensation. If an overdose is suspected, contact your doctor or pharmacist immediately. If you forget to take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> If you forget to take <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets>, take it as soon as you remember. However, do not take a double dose to make up for a forgotten tablet. If you stop taking <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> If you wish to interrupt or prematurely discontinue the treatment, please consult your doctor. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> can cause side effects, although not everybody gets them. The evaluation of side effects is based on the following frequencies: very common: affects more than 1 user in 10 Common: affects 1 to 10 users in 100 Uncommon: affects 1 to 10 users in 1,000 Rare: affects 1 to 10 users in 10,000 Very rare: affects less than 1 user in 10,000 Not known: frequency cannot be estimated from the available data Stop taking <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> and contact a doctor immediately if you experience the following possible adverse reactions: Rare side effects: - feeling sick (nausea), diarrhoea, abdominal pain, constipation, wind (flatulence), bloating (abdominal distension), stomach ache. - rash, itching, hives. 4

Uncommon side effects: - high levels of calcium in your blood (hypercalcaemia: a high blood calcium level, with potential symptoms of excessive thirst, nausea, vomiting, lack of appetite, constipation, stomache ache, bone pain, a need to pass more water than usual, muscle weakness, drowsiness, confusion, fatique and in severe cases irregular heart beat) or urine (hypercalciuria). Very rare side-effects: - Milk alkali syndrome (usually only seen in overdose see if you take more than you should ) Frequency not known: - Hypersensitivity reactions such as swelling of the face, tongue, lips (angioedema) or swelling of the throat (laryngeal oedema) with sudden difficulty breathing and severe rash. - If you have impaired renal function, you may be at risk of increased amounts of phosphate in the blood, renal stone formation and increased amounts of calcium in the kidneys. Reporting of side effects If you get any side effects, talk to your <doctor> <or> <,> <pharmacist> <or nurse>. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE <CALCIUM 1000 MG / VITAMIN D 3 880 IU, CHEWABLE TABLETS> Keep out of the reach and sight of children. Do not use <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> after the expiry date (EXP) which is stated on the carton and on the tablet container or on the laminated aluminium paper foil. The expiry date (EXP) refers to the last day of that month. For tablet container: Keep the tablet container tightly closed in order to protect from moisture. For strips: This medicinal product does not require any special storage conditions. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> contains - The active substances are calcium and colecalciferol. Each chewable tablet contains 2,500 mg of calcium carbonate (equivalent to 1,000 mg of calcium) and 8.8 mg of colecalciferol concentrate (powder form) (equivalent to 22 micrograms of colecalciferol = 880 IU of vitamin D 3). - The other ingredients are isomalt (E953), xylitol, sorbitol (E420), citric acid, anhydrous, sodium dihydrogen citrate, magnesium stearate, carmellose sodium, flavour orange CPB and flavour orange CVT (which both contain sorbitol (E420)), aspartame (E951), acesulfam potassium, sodium ascorbate, all-rac-alpha-tocopherol, modified (maize) starch, sucrose, triglycerides medium chain and silicon dioxide colloidal. What <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> looks like and contents of the pack <Calcium 1000 mg / Vitamin D 3 880 IU, chewable tablets> are round, white tablets with faultless surface and a breakmark. The tablet can be divided into equal halves. The chewable tablets are available in polypropylene tablet containers with polyethylene stoppers containing a desiccant in the following package sizes: DE/H/2857/001/DC: 10, 20, 30, 40, 50, 60, 90, 100 (bundling package 5x20) chewable tablets 5

DE/H/2858/001/DC: 1 or 3 tablet containers of 30 chewable tablets DE/H/2859/001/DC: 10, 20, 30, 40, 50, 60, 90, 100 (bundling package 5x20) chewable tablets DE/H/2860/001/DC: 10, 20, 28, 30, 40, 50, 56, 60, 90, 100 (bundling package 5x20) chewable tablets DE/H/2924/001/DC: 10, 20, 30, 40, 50, 60, 90, 100 (bundling package 5x20) chewable tablets DE/H/2925/001/DC: 20, 28, 30, 50, 56, 60, 90, 100 (bundling package 5x20) chewable tablets The chewable tablets are available in strips of laminated aluminium paper foil in the following package sizes: DE/H/2856/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2857/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2858/001/DC: 30, 90 chewable tablets DE/H/2859/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96 100 (bundling package 5x20) chewable tablets DE/H/2860/001/DC: 10, 20, 28, 30, 40, 48, 56, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2924/001/DC: 10, 20, 30, 40, 48, 60, 60 (bundling package 2x30), 90, 90 (bundling package 3x30), 96, 100 (bundling package 5x20) chewable tablets DE/H/2925/001/DC: 20, 28, 30, 48, 56, 60, 90, 96, 100 (bundling package 5x20) chewable tablets Not all pack sizes may be marketed. Marketing Authorisation Holder [To be completed nationally] {Name and address} {tel} {fax} {e-mail} Manufacturer Hermes Arzneimittel GmbH Georg-Kalb-Straße 5-8 82049 Großhesselohe / Munich Germany This medicinal product is authorised in the Member States of the EEA under the following names: [To be completed in the final PL] This leaflet was last approved in {MM/YYYY}. [To be completed nationally] 6